The FDA has refused to review Moderna's application to sell a new flu shot, the latest move by the administration against vaccines

Core Viewpoint - The company announced that the agency would not review its application due to insufficient testing in the study for the shot [1] Group 1 - The agency's decision is based on the inadequacy of the study testing the shot [1]